These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28413591)

  • 1. Comparative evaluation of efficacy of subgingivally delivered 1.2% Atorvastatin and 1.2% Simvastatin in the treatment of intrabony defects in chronic periodontitis: a randomized controlled trial.
    S Martande S; Kumari M; Pradeep AR; Pal Singh S; Kumar Suke D
    J Dent Res Dent Clin Dent Prospects; 2017; 11(1):18-25. PubMed ID: 28413591
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of subgingivally delivered simvastatin in the treatment of patients with type 2 diabetes and chronic periodontitis: a randomized double-masked controlled clinical trial.
    Pradeep AR; Rao NS; Bajaj P; Kumari M
    J Periodontol; 2013 Jan; 84(1):24-31. PubMed ID: 22420871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of subgingivally delivered simvastatin in the treatment of patients with chronic periodontitis: a randomized clinical trial.
    Pradeep AR; Thorat MS
    J Periodontol; 2010 Feb; 81(2):214-22. PubMed ID: 20151799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Subgingivally Delivered 1.2% Atorvastatin in the Treatment of Chronic Periodontitis in Patients With Type 2 Diabetes Mellitus: A Randomized Controlled Clinical Trial.
    Kumari M; Martande SS; Pradeep AR; Naik SB
    J Periodontol; 2016 Nov; 87(11):1278-1285. PubMed ID: 27442085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin local drug delivery in smokers with chronic periodontitis: a randomized controlled clinical trial.
    Rao NS; Pradeep AR; Bajaj P; Kumari M; Naik SB
    Aust Dent J; 2013 Jun; 58(2):156-62. PubMed ID: 23713634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1.2% Rosuvastatin Versus 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Placebo-Controlled Clinical Trial.
    Pradeep AR; Garg V; Kanoriya D; Singhal S
    J Periodontol; 2016 Jul; 87(7):756-62. PubMed ID: 26878748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical efficacy of subgingivally delivered 1.2% atorvastatin in chronic periodontitis: a randomized controlled clinical trial.
    Pradeep AR; Kumari M; Rao NS; Martande SS; Naik SB
    J Periodontol; 2013 Jul; 84(7):871-9. PubMed ID: 23030241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sub-gingival delivery of simvastatin and rosuvastatin for treatment of chronic periodontitis with diabetes mellitus: A randomized controlled clinical-radiographic pilot study.
    Sharma P; Singh A; Mallapragada S
    J Oral Biol Craniofac Res; 2023; 13(2):315-320. PubMed ID: 36891284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial.
    Shirke PY; Kolte AP; Kolte RA; Bawanakar PV
    J Dent Res Dent Clin Dent Prospects; 2019; 13(3):183-191. PubMed ID: 31857864
    [No Abstract]   [Full Text] [Related]  

  • 10. Subgingivally delivered 1.2% atorvastatin in the treatment of chronic periodontitis among smokers: a randomized, controlled clinical trial.
    Kumari M; Martande SS; Pradeep AR
    J Investig Clin Dent; 2017 May; 8(2):. PubMed ID: 26988864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Efficacy of Subgingivally Delivered 1.2 mg Simvastatin in the Treatment of Patients with Aggressive Periodontitis: A Randomized Controlled Clinical Trial.
    Priyanka N ; Abhilash A; Saquib S; Malgaonkar N; Kudyar N; Gupta A; Kalra N; Pradeep AR
    Int J Periodontics Restorative Dent; 2017; 37(2):e135-e141. PubMed ID: 28196160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy of subgingivally delivered 1.2-mg simvastatin in the treatment of individuals with Class II furcation defects: a randomized controlled clinical trial.
    Pradeep AR; Priyanka N; Kalra N; Naik SB; Singh SP; Martande S
    J Periodontol; 2012 Dec; 83(12):1472-9. PubMed ID: 22348696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-Rich Fibrin Combined With 1.2% Atorvastatin for Treatment of Intrabony Defects in Chronic Periodontitis: A Randomized Controlled Clinical Trial.
    Martande SS; Kumari M; Pradeep AR; Singh SP; Suke DK; Guruprasad CN
    J Periodontol; 2016 Sep; 87(9):1039-46. PubMed ID: 27294433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of subgingivally delivered 1% alendronate versus 1.2% atorvastatin gel in treatment of chronic periodontitis: a randomized placebo-controlled clinical trial.
    Pradeep AR; Kanoriya D; Singhal S; Garg V; Manohar B; Chatterjee A
    J Investig Clin Dent; 2017 Aug; 8(3):. PubMed ID: 27091596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of subgingivally delivered 1.2% rosuvastatin and 1% metformin gel in treatment of intrabony defects in chronic periodontitis: A randomized controlled clinical trial.
    Pankaj D; Sahu I; Kurian IG; Pradeep AR
    J Periodontol; 2018 Nov; 89(11):1318-1325. PubMed ID: 29802627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of subgingivally delivered simvastatin gel in chronic periodontitis patients.
    Agarwal S; Chaubey KK; Chaubey A; Agarwal V; Madan E; Agarwal MC
    J Indian Soc Periodontol; 2016; 20(4):409-416. PubMed ID: 28298823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial.
    Garg S; Pradeep AR
    J Periodontol; 2017 Mar; 88(3):259-265. PubMed ID: 27715376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of locally delivered 1.2% rosuvastatin gel to non-surgical treatment of patients with chronic periodontitis: a randomized, placebo-controlled clinical trial.
    Pradeep AR; Karvekar S; Nagpal K; Patnaik K; Guruprasad CN; Kumaraswamy KM
    J Periodontol; 2015 Jun; 86(6):738-45. PubMed ID: 25786565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of the clinical and radiographic efficacy of 0.05% zoledronate gel as local drug delivery system in treating intrabony defects in stage III grade B periodontitis patients with and without type-2 diabetes mellitus-A randomized split-mouth clinical trial.
    Raj SC; Mishra AK; Mohanty D; Katti N; Pattnaik S; Patra L; Pattanaik A
    Clin Adv Periodontics; 2023 Jul; ():. PubMed ID: 37475545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Locally delivered 1% metformin gel in the treatment of smokers with chronic periodontitis: a randomized controlled clinical trial.
    Rao NS; Pradeep AR; Kumari M; Naik SB
    J Periodontol; 2013 Aug; 84(8):1165-71. PubMed ID: 23130655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.